On March 13, 2025, the Federal Circuit issued a decision in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc., No. 23-2254 (Fed. Cir. 2025) ...

“We are excited to collaborate with Scienture to enhance its commercial effectiveness,” said Paul Mignon, President, Deployment Solutions, Syneos Health. “Our team is committed to delivering tailored ...

Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...

AM(IST)on Tuesday in an upbeat market. Abbott India Ltd.(up 0.74 per cent), Gland Pharma Ltd.(up 0.68 per cent), Biocon ...

Stocks like Reliance Industries, Apollo Hospitals Enterprise, Power Grid Corporation, Allied Blenders and Distillers, ...

Experts underestimated Trump's seriousness on tariffs; Indian auto and pharma sectors brace for impact, while steel remains ...

Curateq Biologics, a wholly owned subsidiary of Aurobindo Pharma, has allotted 4,125,055 Compulsory Convertible Preference Shares (CCPSs) of Rs.10/- each to Dr. Satakarni Makkapati on 20 March 2025.

Aurobindo Pharma Ltd - Allotment Of Compulsory Convertible Preference Shares To Dr. Satakarni Makkapati By Curateq Biologics Private Limited, A Wholly Owned Subsidiary Of The Company.

Here are the local and international drugmakers also eyeing the Indian market and looking to introduce rivals to Lilly's drug ...

ET Intelligence Group: The stock of Aurobindo Pharma has lost 13% in 2025 so far, underperforming the 10% drop in the BSE ...

Telangana: Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma, has received an Establishment ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...